本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

18.19
-0.2500-1.36%
成交量:7,041
成交额:12.83万
市值:6,233.89万
市盈率:6.86
高:18.35
开:18.35
低:18.19
收:18.44
52周最高:21.43
52周最低:6.27
股本:342.71万
流通股本:342.71万
量比:1.63
换手率:0.21%
股息:- -
股息率:- -
每股收益(TTM):2.65
每股收益(LYR):-2.6890
净资产收益率:-746.25%
总资产收益率:-32.37%
市净率:2.80
市盈率(LYR):-6.76

数据加载中...

2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/05/11

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

Current report, items 2.02 and 9.01
2020/03/16

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/22

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]